To further its mission to educate, lead, and serve, the American College of Toxicology is proud to offer a new eLearning Seminar focused on Gene Therapy. These four modules are intended to provide insight into gene therapy development for practicing toxicology professionals. The modules will feature recognized experts who will highlight the nonclinical and regulatory strategies, challenges encountered, and lessons learned from discovery to market, and beyond.
Modules will be available for purchase individually or as a discounted set of four modules. Once the live module presentations conclude, registrants will have on-demand access to the modules for 30 days from the time each archive is first accessed. Each module is 90 minutes or fewer in duration.
All live module presentations are scheduled at 11:00 AM Eastern Time
Module 4: Thursday, April 21, 2022
Approved Gene Therapy Products: Case Studies
Tim MacLachlan, PhD, DABT
Peter Ulrich, PhD, DABT, ERT
View Module 4 Abstract (MacLachlan)
View Module 4 Abstract (Ulrich)
As part of your registration, you will have unlimited access to either the individual module or set of modules recordings for 30 days. The 30-day access will begin when you access each individual module link. Certificates will be provided for each module. If you have any additional questions, please contact ACT Headquarters.
Seminar registration is restricted to single-person use only.
|Per Module||Set/Modules 1–4|
|ACT Student/Postdoctoral Researcher Members||$35||$125|